There is a specific kind of silence that exists in a doctor’s office right before a diagnosis is delivered. It is a heavy, expectant silence. In that small room, the world shrinks down to two people: the one seeking help and the one offering a path forward. It is a moment defined by an invisible, fragile thread of trust.
Dr. Lobna Salem remembers that silence well. Before Dr. Salem was a corporate executive overseeing medical affairs for a global healthcare company, she was simply a student of the human body, driven by wanting to know how we work, why we break, and how to put us back together. But more than the mechanics of biology, she was drawn to medicines that gave her the perfect intersection of science, purpose, and human connection. An impact that matters.
Today, Dr. Lobna Salem is the Chief Medical Officer at Viatris, leading a global Medical Affairs organization. Her office is no longer a clinical exam room. The scale of her impact has moved beyond the walls of a clinical exam room and has expanded from one patient at a time to millions across geographies, health systems, and therapeutic areas.
She now operates at the intersection of evidence generation, regulatory framework, scientific exchange, and access to patients. Her daily work moves through clinical development plans, real-world evidence frameworks, publication strategy, health authority dialogue, and cross-functional governance. It is a world defined by data integrity, compliance boundaries, and the disciplined independence that Medical Affairs must uphold.
And yet — if you listen to her speak — you realize she never truly left that small clinical exam room. She simply expanded it. The questions are the same: Is this evidence meaningful? Does this improve patient outcomes? Are we acting responsibly? Medical Affairs, at its best, is the scaled expression of bedside medicine — protecting scientific rigor, safeguarding patient safety, and ensuring that innovation translates into real-world impact.
The room is larger now. The responsibility is heavier. But the pulse remains human.
The Intersection of Science and Purpose
Dr. Salem’s journey began with an observation. “From an early age, I was driven by a deep curiosity about the human body and an even deeper desire to make a meaningful impact on people’s lives,” she reflects.
For many, medicine is a technical pursuit, a mastery of anatomy and chemistry. In Dr. Salem’s early years in clinical training, she saw the gaps. She saw the unmet needs. She saw that a physician’s skill is only as good as the system that allows them to deliver care.
Working across diverse healthcare systems gave her a perspective that was both broad and granular. She saw how access and equity, or the lack thereof, dictated patient outcomes. It was a realization that slowly shifted her trajectory.
“Over time, I realized that I could influence far more lives by helping shape the systems, policies, and innovations that determine how care is delivered worldwide,” she says.
This understanding guided Dr. Salem’s transition from frontline medicine into Medical Affairs and eventually global healthcare leadership. It requires a leap of faith that your work in medicine and strategy in pharma will continue to impact patients. Dr. Salem made that leap. She moved into Medical Affairs, a discipline that sits at the nexus of research, clinical development, and commercialization, eventually rising to global healthcare leadership.
The Value of the Role
As the Chief Medical Officer of Viatris, Dr. Salem oversees Global Medical Affairs. It is a title that carries a deceptively simple description but a staggering weight of complexity.
Viatris is a company with a global footprint. Dr. Salem’s role, alongside her Viatris colleagues, is to ensure that this mission is translated into scientific reality. She oversees evidence generation, scientific strategy, medical quality, medical external partnerships, and medical governance across a portfolio that includes both innovative therapies and essential branded medicines.
“My primary responsibility is to ensure that every Medical Affairs decision we make is grounded in scientific integrity, patient safety, and medical value,” Dr. Salem explains.
This is where the job becomes a balancing act. Balancing rigor and operational demands requires strategic vision and executional discipline. There is a need for operational agility; the drive to innovate, to move quickly, to get medicines to markets where they are desperately needed. On the other side is the absolute, immovable need for scientific rigor and patent safety.
“Scientific rigor ensures our data and decisions are credible. Patient safety defines our purpose and guardrails.” Dr. Salem explains.
It is a role that requires her to be a harmonizer. She and her teams have to ensure that innovation is accelerated without ever compromising the quality of medical support. Priorities include ensuring her teams are empowered to execute quickly and ethically across the globe, and most importantly, that the patient’s voice is heard.
Trust, she often says, is safeguarded by independence. It is earned by Medical Affairs as it stands firmly on scientific integrity — guided by evidence. It is strengthened through transparency, disciplined accountability, and an unwavering focus on patients. Engagements with healthcare professionals and researchers are not promotional moments, but independent scientific exchanges that ensure decisions remain anchored in what is right for patients.
Anchoring the Mission
Viatris occupies a unique space in the healthcare ecosystem. It is not solely focused on chasing the next “blockbuster” drug, nor is it purely a generics manufacturer. It is a mix that strives to ensure access while advancing science to address pressing health challenges.
“As CMO, my role is to anchor the Medical Affairs organization’s contribution to this mission in science,” Dr. Salem says.
She views Medical Affairs as the anchor. With both commercial demands and shifting market dynamics, science must hold firm. Her team ensures that medicines are supported by robust data and communicated responsibly.
The therapeutic innovation reflects where the burden of disease remains highest and where unmet medical needs continue to shape patient outcomes worldwide. Among many areas of unmet medical needs and high disease burden are cardiometabolic diseases, immunology and autoimmune conditions, where scientific advances are rapidly evolving; acute and chronic pain, where safer and more effective options remain urgently needed; and psychiatry and mental health conditions that remain significantly underdiagnosed.
These are not abstract categories; they represent the lived realities of millions of patients navigating chronic illness, disability, and inadequate treatment options. By focusing here, Dr. Salem and Viatris’ colleagues are directing the company’s resources toward the areas of greatest human need.
The Principles of a Leader
When you strip away the corporate structure and the medical terminology, you are left with the values of the leader. Dr. Salem’s approach to leadership is surprisingly intimate.
“Four principles have always grounded my leadership,” she states.
First is the purpose before the position. “Every role is an opportunity to serve patients and society,” she says. It is a reminder that the title is temporary, but the impact is permanent.
Second is scientific integrity. Data, transparency, and rigor must always lead. In a field where cutting corners can cost lives, this is non-negotiable.
Third is courage with compassion. “Leadership requires making difficult decisions while uplifting people in the process,” Dr. Salem observes. It is easy to be decisive; it is hard to make firm choices without losing compassion is no small feat.
Fourth, and perhaps most striking for a senior executive, is to acknowledge vulnerability. She believes in being relatable, in grounding her experience in reality.
“These values help me remain anchored amid complexity and ensure that the teams I lead feel inspired and empowered,” she says.
This philosophy was put to the test during the inception of Viatris. It was a period of significant organizational transformation. The Medical Affairs function was evolving rapidly. The operating model had to be redefined while maintaining quality and navigating the uncertainty that comes with any major merger or restructuring.
“My leadership was tested in my ability to provide clarity and create stability while reshaping the Medical Affairs organization,” Dr. Salem recalls.
She didn’t retreat; she communicated transparently. She engaged teams at every level. She reinforced the mission. The result was not just a survival of the transition, but the creation of a stronger, more resilient medical affairs team.
Evidence of Impact
For a Chief Medical Officer, the metrics are measured in reach, in recognition, and in the quality of the team.
Dr. Salem looks at Viatris with pride. Within her realm, she points to the establishment of a “best-in-class Viatris Medical Affairs Organization” filled with unique talents. She highlights the deep scientific expertise her team has cultivated across both the innovative and established portfolios.
There have been external accolades, such as the PM360 Pharma Choice Gold Award for medical-to-medical communication. But perhaps the most telling metric is the reach of the NCD (Non-Communicable Disease) Academy, an innovative, free online platform developed and operated by the American College of Cardiology in collaboration with the NCD Alliance and the World Heart Federation.
“Reaching 100 million patients through NCD Academy as per our company’s communicated objective,” she notes.
That number, 100 million, is staggering. It represents a scale of impact that justifies her decision years ago to leave clinical practice. By empowering primary care doctors with education on non-communicable diseases, Viatris has been able to impact more lives as a collective than she could have in a hundred lifetimes of individual consultations.
The Future of Care
Dr. Salem is not a leader who spends much time looking in the rearview mirror. Her eyes are fixed on the horizon. She sees a healthcare landscape that is shifting under our feet.
“The next decade will be shaped by precision therapeutics and targeted delivery platforms,” she predicts, citing peptides and oligonucleotides as examples.
She sees a future driven by AI-enabled evidence generation and clinical decision support. She anticipates that regulatory and payer decisions will increasingly be driven by RWE (Real World Evidence), moving beyond the controlled environment of clinical trials to the messy reality of everyday life.
She talks about the integration of digital biomarkers and remote monitoring, and the next generation of treatments for cardiometabolic and immunological conditions.
But beneath the technology, her vision remains human. “The future belongs to organizations that can blend advanced science with human insight and real-world relevance,” she says. “Patient-centered innovation, shaping therapies not only for efficacy but for usability, equity, and outcomes.”
Her personal ambition aligns with this professional vision. She wants to contribute to an ecosystem where “innovation is accelerated, evidence is democratized, and equitable access is the norm—not the aspiration.”
The Intentional Balance
Contributing in a meaningful way towards a global organization is a relentless pursuit. It follows you home. It lives in your phone. How does one manage it without burning out?
Dr. Salem rejects the idea of a “perfect” work-life balance. “I’ve learned that balance is less about perfection and more about intentionality,” she says.
For her, the key is presence. When she is at work, she is fully there. When she is with her family, she is fully with them. She creates space for herself through travel and walking in nature; practices that reconnect her with clarity and creativity. These are not distractions from her work; they are the fuel for it. They restore the energy she needs to lead with resilience and empathy.
The Message
Dr. Salem is a professional who has traveled a long way from the initial curiosity of a young student. She has navigated the complexities of global health, managed transformations, and led teams across borders. Yet, her core message remains simple. It is a call to action for anyone who aspires to lead.
“Lead with purpose, act with courage and humility, and never lose sight of the impact your work can have on people’s lives,” she says.
In a world that often tries to separate science from emotion, Dr. Salem insists they belong together.
“In medicine and in leadership, the most transformative outcomes come when science, compassion, and conviction move together.”
Viatris supports a movement that never loses the human heartbeat that drives it. Guided by leaders like Dr. Salem, the organization aspires to build and sustain a culture where purpose, integrity, and human-centered leadership form the foundation of everything it does.
Quote
